EUVIMEDEUVIMED entdecken
Open Access

Physical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors

Clara Bodelon, Matthew Masters, Den E Bloodworth, Peter J Briggs, Erika Rees-Punia, Lauren E McCullough, Alpa V Patel, Lauren R Teras

JAMA Network Open · 28.02.2025 · 8 (2) · e2462365

DOI: 10.1001/jamanetworkopen.2024.62365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 28.02.2025. Verfasst von Clara Bodelon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Science, American Cancer Society, Atlanta, Georgia. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Antineoplastic Agents, Hormonal, Health Status. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Women with a history of breast cancer (BC) experience greater physical health decline compared with age-matched women without cancer. However, whether this decline differs in patients who received chemotherapy and endocrine therapy is not well understood.

Objective

To investigate physical health decline in BC survivors who received chemotherapy or endocrine therapy compared with age-matched women without cancer. Design, Setting, and Participants This prospective cohort study was conducted as part of the Cancer Prevention Study-3, a prospective US cohort study that enrolled participants in 35 states, the District of Columbia, and Puerto Rico between 2006 and 2013. Follow-up for this analysis was through April 1, 2020. Statistical analyses were conducted between May 2023 and December 2024. Female participants diagnosed with nonmetastatic BC who returned a survey at least 90 days after their diagnosis were matched on age and year of survey return with up to 5 women without cancer. Exposure Cancer status and treatment information. Main Outcomes and Measures Outcomes of interest were measures of physical health, assessed using the Patient-Reported Outcomes Measurement Information System Global Health Scale instrument. Linear regression was used to estimate associations (β) and 95% CIs of treatment with physical health.

Results

This analysis included 2566 individuals diagnosed with BC and 12 826 age-matched women without cancer. Median (IQR) age at diagnosis was 56.3 (49.9-61.9) years. Of women with BC, 1223 (47.7%) received endocrine therapy, 276 (10.8%) received chemotherapy, and 634 (24.7%) received both. Compared with women without cancer, there was a greater physical health decline within 2 years of diagnosis for BC survivors receiving endocrine therapy (β = −1.12; 95% CI, −1.64 to −0.60), chemotherapy (β = −3.13; 95% CI, −4.19 to −2.07), or both (β = −3.26; 95% CI, −3.97 to −2.55). The decline among endocrine therapy users was restricted to women receiving aromatase inhibitors. More than 2 years after diagnosis, the decline was only observed in women who received chemotherapy. Conclusions and Relevance In this cohort study of 15 392 BC survivors and age-matched women without cancer, BC survivors who received chemotherapy had a long-lasting physical health decline, unlike survivors who received endocrine therapy without chemotherapy. Further studies are needed to confirm these results and to better understand the health consequences of these treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCancer SurvivorsAntineoplastic Agents, HormonalHealth StatusAntineoplastic AgentsHumansFemaleMiddle AgedProspective StudiesAgedUnited StatesAdult

Substanzen

Antineoplastic Agents, HormonalAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Population Science, American Cancer Society, Atlanta, Georgia.
  • Emory University Rollins School of Public Health, Emory University, Atlanta, Georgia.

Zitieren

APA

Bodelon, C., Masters, M., Bloodworth, D. E., Briggs, P. J., Rees-Punia, E., McCullough, L. E., Patel, A. V., & Teras, L. R. (2025). Physical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors. JAMA Network Open, 8(2), e2462365. https://doi.org/10.1001/jamanetworkopen.2024.62365

Vancouver

Bodelon C, Masters M, Bloodworth DE, Briggs PJ, Rees-Punia E, McCullough LE, et al. Physical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors. JAMA Network Open. 2025;8(2):e2462365. doi:10.1001/jamanetworkopen.2024.62365

BibTeX
@article{Bodelon2025,
  author = {Bodelon, Clara and Masters, Matthew and Bloodworth, Den E and Briggs, Peter J and Rees-Punia, Erika and McCullough, Lauren E and Patel, Alpa V and Teras, Lauren R},
  title = {Physical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {2},
  pages = {e2462365},
  doi = {10.1001/jamanetworkopen.2024.62365}
}
Kostenlos starten →